IRIS - Res&Arch Institutional Research Information System - Research & Archive

CAMILLONI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.307
AS - Asia 2.509
EU - Europa 2.388
SA - Sud America 446
AF - Africa 29
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.689
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.216
SG - Singapore 1.025
IE - Irlanda 522
HK - Hong Kong 434
UA - Ucraina 434
VN - Vietnam 396
BR - Brasile 378
CN - Cina 358
IT - Italia 312
RU - Federazione Russa 289
DE - Germania 243
FI - Finlandia 165
KR - Corea 120
SE - Svezia 117
GB - Regno Unito 76
CA - Canada 51
FR - Francia 48
TR - Turchia 40
AT - Austria 33
MX - Messico 32
AR - Argentina 27
PL - Polonia 25
BE - Belgio 22
IN - India 21
BD - Bangladesh 19
CH - Svizzera 18
JP - Giappone 16
NL - Olanda 16
EC - Ecuador 14
ID - Indonesia 14
ES - Italia 12
PT - Portogallo 12
ZA - Sudafrica 11
CZ - Repubblica Ceca 10
LB - Libano 9
LT - Lituania 9
UZ - Uzbekistan 9
IQ - Iraq 8
GR - Grecia 7
PK - Pakistan 7
PY - Paraguay 7
AU - Australia 6
CL - Cile 5
CO - Colombia 5
BG - Bulgaria 4
GH - Ghana 4
MA - Marocco 4
PE - Perù 4
RO - Romania 4
EU - Europa 3
OM - Oman 3
PH - Filippine 3
RS - Serbia 3
SA - Arabia Saudita 3
VE - Venezuela 3
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CR - Costa Rica 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
NP - Nepal 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
NE - Niger 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SO - Somalia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TN - Tunisia 1
UY - Uruguay 1
Totale 8.689
Salva come PNG Salva come JPEG
Città #
Singapore 693
Chandler 541
Dublin 521
Hong Kong 434
Dong Ket 290
San Mateo 240
Jacksonville 238
Ashburn 190
Boardman 166
Santa Clara 143
Medford 115
Princeton 115
Munich 108
Seoul 104
Beijing 101
Moscow 101
Perugia 99
Wilmington 82
Andover 73
Ann Arbor 72
Los Angeles 58
Ho Chi Minh City 53
New York 42
São Paulo 41
Altamura 38
Helsinki 38
Piscataway 36
Izmir 33
Lawrence 32
Turku 31
Columbus 30
Saint Petersburg 28
Des Moines 24
Genoa 23
London 22
Falls Church 21
Norwalk 21
Brooklyn 20
Ottawa 20
The Dalles 20
Rome 19
Vienna 19
Redwood City 18
Houston 17
Nuremberg 17
Redmond 17
Warsaw 17
Hanoi 16
Frankfurt am Main 15
Boston 14
Dongjak-gu 14
Tokyo 14
Brussels 13
Denver 13
Montreal 12
Hefei 11
Mexico City 11
Chicago 10
Dallas 10
Florence 10
Stockholm 10
Terni 10
Johannesburg 9
Toronto 9
Woodbridge 9
Amsterdam 8
Curitiba 8
Orem 8
Rio de Janeiro 8
Seattle 8
Shanghai 8
Falconara Marittima 7
Milan 7
Porto Alegre 7
Ankara 6
Belo Horizonte 6
Chennai 6
Corciano 6
Da Nang 6
Den Haag 6
Düsseldorf 6
Jakarta 6
Longueville 6
Phoenix 6
Porto 6
San Francisco 6
Secaucus 6
Sorocaba 6
Zhengzhou 6
Atlanta 5
Changsha 5
Duque de Caxias 5
Gualdo Cattaneo 5
Guarulhos 5
Olomouc 5
San Paolo di Civitate 5
Shijiazhuang 5
Asunción 4
Campinas 4
Franca 4
Totale 5.602
Salva come PNG Salva come JPEG
Nome #
10-Year Rotavirus Infection Surveillance: Epidemiological Trends in the Pediatric Population of Perugia Province 179
Antibody response and protection after intradermal and intramuscular 2011/2012 trivalent influenza vaccination in elderly volunteers 128
Antibodies cross-reactive to seasonal influenza A(H1N1)pdm09 viruses in human sera of elderly people immunized with trivalent influenza vaccines containing the A/California/7/09 vaccine strain 114
Anti-Biofilm Properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 Probiotics against G. vaginalis 110
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial 109
Antibody Responses after Influenza Vaccination in Elderly People: Useful Information from a 27-Year Study (from 1988–1989 to 2014–2015) 107
Annually repeated influenza vaccination and humoral response in elderly volunteers. 104
Accelerate Pheno™ blood culture detection system: a literature review 104
Influenza vaccination in patients on long-term anticoagulant therapy. 102
A novel methodology based on serological data for improving precision in the influenza vaccine response of non-seroprotected 102
Molecular analysis of Group of Rotaviruses detected in subjects with severe acute gastroenteritis in Umbria from 2006 to 2012 100
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 100
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59 adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. 96
An influenza A/H3 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home. 94
An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in Italy. 94
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature 94
An influenza A/H3 outbreak during the 2004/2005 winter in elderlyvaccinated people living in a nursing home 93
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age. 92
Influenza vaccination in patients on long-term anticoagulant therapy 92
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 91
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine 91
Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulatingA(H3N2)strains 88
Antibody response elicited by 2012/2013 “implemented influenza vaccines”, FLUAD® (Novartis Vaccines & Diagnostics) and INTANZA® 15Mcg (Sanofi Pasteur MSD), in chronically ill institutionalized elderly volunteers 88
Antibody response against unchanged influenza vaccine components in elderly people vaccinated in consecutive years 88
An influenza outbreak in elderly vaccinated people in the winter season 2007/2008 86
Differente risposta anticorpale al vaccine anti-influenzale per l’inverno 2008/2009 in soggetti anziani residenti in due differenti case di riposo. 86
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. 85
A G12P[8] rotavirus gastroenteritis outbreak in Italy, 2013 85
L’influenza in Umbria nell’inverno 2005/06 83
Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. 83
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages 83
Induzione di risposta immunitaria e di protezione da parte dei vaccini antinfluenzali in soggetti anziani. 83
null 83
Role of nucleocapsid protein antigen detection for safe end of isolation of sars-cov-2 infected patients with long persistence of viral rna in respiratory samples 83
Immunogenicity of conventional trivalent inactivated influenza vaccines in pre-vaccination unprotected elderly volunteers in five winters seasons. 82
Influenza vaccine immunogenicity and efficacy in istitutionalized elderly volunteers (winter season 2002/03). 82
Influenza vaccine induced antibody response against B influenza viruses included in the vaccine or naturally circulating during the winter season 2010/2011 82
Accuracy and impact on patient management of new tools for diagnosis of sepsis: Experience with the t2 magnetic resonance bacteria panel 82
The effect of influenza vaccination in patients on long-term oral anticoagulant therapy 79
Delivery in asymptomatic Italian woman with SARS-CoV-2 infection 79
Comparative study of immunogenicity of split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 76
Comparative study on immunogenicity among split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 75
Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (winters 2003/04 and 2007/08). 74
Cross-reactive antibodies to viruses of both B/Victoria and B/Yamagata lineages as induced by influenza vaccination in middle-aged and elderly volunteers 72
Immunization with adjuvanted and non-adjuvanted influenza vaccines of HIV-1 positive patients treated with highly active antiretroviral therapy (HAART) 72
Vaccination against paediatric respiratory pathogens 72
Drugs for Influenza Treatment: Is There Significant News? 72
Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021 72
Immunogenicity of the MF-59-adjuvanted vaccine in volunteers of different group of age. 71
Clinical characteristics of influenza A/H1N1, A/H3N2 and B infections in children during three consecutive winter seasons (2012-13, 2013-14 and 2014-15) 71
Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) 71
First detection of a reassortant G3P[8] rotavirus Astrain in Italy: a case report in an 8-year-old child 71
Declined antibody response following influenza vaccination in elderly as compared with middle-aged volunteers: effects of aging and/or original antigenic sin? 70
Pro-inflammatory cytokines/ chemokines production after infection of A549 Human epithelial cell line with different strains of human influenza viruses 69
Pandemic Influenza A/H1N1pdm in Italy: Age, Risk and Population Susceptibility 69
Hospital‐acquired rotavirus acute gastroenteritis in 10 consecutive seasons in Umbria (Italy) 69
UN MAGGIORE UTILIZZO DI SIERI UMANI PUO’ CONTRIBUIRE AD UNA MIGLIORE CARATTERIZZAZIONE ANTIGENICA DEI VIRUS INFLUENZALI PER LA SCELTA DELLE COMPONENTI VACCINALI 68
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. 67
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 66
The intersubunit region of influenza virus haemagglutinin as a peptide vaccine candidate. 65
Multiplex platforms for the identification of respiratory pathogens: Are they useful in pediatric clinical practice? 65
Flow cytometric analysis of intracellular antigen-specific interferon-gamma in human NK and T populations after influenza vaccination 64
Induzione di anticorpi omologhi e cross-reattivi nei confronti di virus influenzali di tipo B da parte del vaccino influenzale nell'inverno 2003/2004 64
Detection of Unusual G6 Rotavirus Strains in Italian Children With Diarrhoea During the 2011 Surveillance Season 64
Hospitalization associated with 2009 pandemic influenza A(H1N1) infection in Umbria, a region of central Italy, July – December 2009. 63
MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and enderly volunteers (winter season 2003/04). 63
VALUTAZIONE DELL’EFFICACIA PROTETTIVA E DELLA CAPACITA’ DI INDURRE ANTICORPI CROSS-REATTIVI NEI CONFRONTI DI VIRUS INFLUENZALI DI TIPO B APPARTENENTI AI LINEAGGI YAMAGATA E VICTORIA DA PARTE DI DUE VACCINI INFLUENZALI TRIVALENTI (FLUAD® E INTANZA®) IN ANZIANI ISTITUZIONALIZZATI 63
Group a rotavirus surveillance before vaccine introduction in italy, september 2014 to august 2017 62
Serologically diagnosed influenza virus A/California/7/04 (H3N2)infection in people immunised with A/Fujan/411/2002(H3N2)antigen during the 2004/05 winter season 62
Influenza vaccine induction of cross–reactive antibodies against different B/Yamagata and B/Victoria-like influenza viruses. , 61
Twenty-seven years experience with immunogenicity of inactivated influenza vaccines in the elderly 61
Vaccinazione antinfluenzale in soggetti HIV-1 positivi trattati con HAART: influenza sulla risposta anticorpale della concentrazione plasmatici di HIV-1 RNA e del numero di CD4+ 60
Partial Protection Induced by 2011–2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People 60
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age 59
Increased immunogenicity of an adjuvanted influenza vaccine compared with a conventional subunit vaccine in non-elderly adult HIV seropositive individuals, treated with HAART 59
Serological methods are able to determine how well influenza vaccines work 59
Immediate reinfection with Omicron variant after clearance of a previous SARS-CoV-2 infection 58
L'influenza: sistemi di sorveglianza e campagne vaccinali 58
Design and validation of a self-administered questionnaire to assess knowledge, attitudes and behaviours about Zika virus infection among general population in Italy. A pilot study conducted among Italian residents in public health 57
Monitoring of indoor bioaerosol for the detection of SARS-CoV-2 in different hospital settings 56
Effect of age on serum heterologous antibody response elicited by inactivated influenza virus vaccine 56
Seroprevalence against pandemic influenza A(H1N1) 2009 after the first season of circulation in Italy 56
Sorveglianza delle paralisi flaccide acute nella regione Umbria 56
Case report: Coxiella burnetii endocarditis in the absence of evident exposure 55
Intracellular influenza antigen-specific cytokines in human T and NK population after influenza vaccination 55
Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017 55
Uncommon G9P[4] group A rotavirus strains causing dehydrating diarrhea in young children in Italy 54
Immunogenicity of subunit and split influenza vaccines and serologically diagnosed influenza infections after vaccination in elderly instituzionalized volunteers (winter season 1999/200) 54
Factors influencing humoral immune response after influenza vaccination in elderly and very elderly subjects 54
Intradermal and intramuscular 2011-2012 influenza vaccination of elderly institutionalized volunteers: induction of antibody responses against vaccine and epidemic influenza virus strains 53
Inhibitor development in mild/moderate haemophilia: could influenza vaccination have been the trigger? 53
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus 53
Diagnosis of infection by SARS-COV-2: Is one molecular test enough? 53
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 52
Efficacy of an inactivated influenza vaccine among well immunized nursing home residents during the 2007/2008 season 52
Laboratory confirmed pandemic H1N1 influenza A virus infections resulting in hospitalization in Umbria, a region of central Italy (May-November 2009) 52
ENDOGENOUS INTERLEUKYN-6 LEVELS AND ANTIBODY RESPONSE TO INACTIVATED INFLUENZA VACCINE IN PLURIVACCINATED ELDERLY VOLUNTEERS 52
Sorveglianza molecolare delle gastroenteriti da rotavirus in Umbria 52
Immunogenicità ed efficacia protettiva del vaccino influenzale per l’inverno 2007/08 in soggetti residenti in casa di riposo 51
Laboratory confirmed pandemic H1N1 influenza virus infections in hospitalization in Umbria, a region of central Italy (May-November 2009). 51
Totale 7.485
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.100
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021607 0 0 0 0 0 42 88 10 75 18 70 304
2021/2022825 17 152 6 21 31 16 7 308 15 14 103 135
2022/20231.622 119 176 14 144 125 181 3 83 694 5 54 24
2023/2024766 70 67 40 15 7 4 183 33 114 20 121 92
2024/20251.964 25 195 58 87 308 91 97 86 361 142 317 197
2025/20261.896 258 256 217 509 531 125 0 0 0 0 0 0
Totale 8.955